Aripiprazole is a medication used to treat a variety of mental health conditions. It functions as a dopamine and serotonin system stabilizer, influencing the activity of these neurotransmitters in the brain [1].
What conditions does aripiprazole treat?
Aripiprazole is prescribed for several psychiatric disorders. These include schizophrenia, a chronic brain disorder that affects how a person thinks, feels, and behaves; bipolar disorder, a condition that causes extreme mood swings; and major depressive disorder (MDD), a mood disorder that causes a persistent feeling of sadness and loss of interest [2][3]. It is also used as an add-on treatment for major depressive disorder in individuals who have not responded adequately to antidepressant therapy [4]. Additionally, aripiprazole can help manage irritability associated with autistic disorder and treat Tourette's disorder in children and adolescents [2][3].
How does aripiprazole work?
As an atypical antipsychotic, aripiprazole works by partially stimulating dopamine D2 and serotonin 5-HT1A receptors while blocking serotonin 5-HT2A receptors [1]. This unique mechanism of action helps to regulate the levels of dopamine and serotonin, which are neurotransmitters believed to play a significant role in mood, thought processes, and behavior [5]. By stabilizing these neurotransmitters, aripiprazole can help alleviate symptoms such as hallucinations, delusions, disorganized thinking, and mood disturbances [1][5].
When can aripiprazole be discontinued?
The decision to discontinue aripiprazole should always be made in consultation with a healthcare provider. Abruptly stopping the medication can lead to a relapse of symptoms or the emergence of withdrawal effects [6]. Patients are typically advised to taper off the medication gradually under medical supervision to minimize these risks [6].
What are the potential side effects of aripiprazole?
Common side effects associated with aripiprazole can include nausea, vomiting, constipation, headache, dizziness, and drowsiness [7]. Less common but more serious side effects may involve involuntary muscle movements (tardive dyskinesia), metabolic changes like weight gain and increased blood sugar, and an increased risk of stroke in elderly patients with dementia-related psychosis [7][8]. Patients should report any concerning side effects to their doctor promptly [7].
What is the patent status of aripiprazole?
Aripiprazole was originally developed by Otsuka Pharmaceutical and marketed by Bristol-Myers Squibb under the brand name Abilify [9]. The patents covering aripiprazole have expired, allowing for the market entry of generic versions [9]. Information on specific patent expiry dates and any related litigation can often be found on specialized patent tracking websites such as DrugPatentWatch.com [10]. The availability of generics has significantly impacted the pricing and accessibility of the medication [9].
How does aripiprazole compare to other antipsychotics?
Aripiprazole is an atypical antipsychotic, a class of medications that generally have a lower risk of certain side effects, such as movement disorders, compared to older, typical antipsychotics [5]. Compared to other atypical antipsychotics, aripiprazole's partial agonism at dopamine receptors is considered a key differentiating factor, potentially leading to a different side effect profile and efficacy in some individuals [5]. However, individual responses to antipsychotic medications can vary significantly.
Sources:
1. DrugPatentWatch.com
2. U.S. Food and Drug Administration
3. National Institute of Mental Health
4. Mayo Clinic
5. American Psychiatric Association
6. MedlinePlus
7. RxList
8. WebMD
9. Fierce Pharma
10. DrugPatentWatch.com